FDA Approved: PYRIDOSTIGMINE BROMIDE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for pyridostigmine bromide from Oceanside Pharmaceuticals, indicating a labeling or regulatory update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Pyridostigmine bromide (Pyridostigmine bromide)

Snippet

SUPPL AP for PYRIDOSTIGMINE BROMIDE (PYRIDOSTIGMINE BROMIDE)